Korean market is latest play for Shield Therapeutics' iron deficiency drug
Pharmaceuticals firm Shield Therapeutics says it has taken a step closer to breaking into the Korean market. The iron deficiency drug specialist, which has operations on Tyneside, says its partner, Korea Pharma Co Ltd, has filed a new drug application (NDA …